323 related articles for article (PubMed ID: 16784462)
21. Novel DOCK clique driven 3D similarity database search tools for molecule shape matching and beyond: adding flexibility to the search for ligand kin.
Good AC
J Mol Graph Model; 2007 Oct; 26(3):656-66. PubMed ID: 17482856
[TBL] [Abstract][Full Text] [Related]
22. Analogs of methyllycaconitine as novel noncompetitive inhibitors of nicotinic receptors: pharmacological characterization, computational modeling, and pharmacophore development.
McKay DB; Chang C; González-Cestari TF; McKay SB; El-Hajj RA; Bryant DL; Zhu MX; Swaan PW; Arason KM; Pulipaka AB; Orac CM; Bergmeier SC
Mol Pharmacol; 2007 May; 71(5):1288-97. PubMed ID: 17308033
[TBL] [Abstract][Full Text] [Related]
23. Flexible 3D pharmacophores as descriptors of dynamic biological space.
Nettles JH; Jenkins JL; Williams C; Clark AM; Bender A; Deng Z; Davies JW; Glick M
J Mol Graph Model; 2007 Oct; 26(3):622-33. PubMed ID: 17395510
[TBL] [Abstract][Full Text] [Related]
24. In silico identification of bioisosteric functional groups.
Ertl P
Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
[TBL] [Abstract][Full Text] [Related]
25. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites.
Schmidtke P; Barril X
J Med Chem; 2010 Aug; 53(15):5858-67. PubMed ID: 20684613
[TBL] [Abstract][Full Text] [Related]
26. Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands.
Macdougall IJ; Griffith R
J Mol Graph Model; 2008 Apr; 26(7):1113-24. PubMed ID: 18023378
[TBL] [Abstract][Full Text] [Related]
27. Parameterization and conformational sampling effects in pharmacophore multiplet searching.
Fox PC; Wolohan PR; Abrahamian E; Clark RD
J Chem Inf Model; 2008 Dec; 48(12):2326-34. PubMed ID: 19053520
[TBL] [Abstract][Full Text] [Related]
28. Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity.
Durdagi S; Papadopoulos MG; Papahatjis DP; Mavromoustakos T
Bioorg Med Chem Lett; 2007 Dec; 17(24):6754-63. PubMed ID: 17980589
[TBL] [Abstract][Full Text] [Related]
29. Complementary three-dimensional quantitative structure-activity relationship modeling of binding affinity and functional potency: a study on alpha4beta2 nicotinic ligands.
Tosco P; Ahring PK; Dyhring T; Peters D; Harpsøe K; Liljefors T; Balle T
J Med Chem; 2009 Apr; 52(8):2311-6. PubMed ID: 19301898
[TBL] [Abstract][Full Text] [Related]
30. SHOP: scaffold HOPping by GRID-based similarity searches.
Bergmann R; Linusson A; Zamora I
J Med Chem; 2007 May; 50(11):2708-17. PubMed ID: 17489578
[TBL] [Abstract][Full Text] [Related]
31. Fluorine in medicinal chemistry.
Böhm HJ; Banner D; Bendels S; Kansy M; Kuhn B; Müller K; Obst-Sander U; Stahl M
Chembiochem; 2004 May; 5(5):637-43. PubMed ID: 15122635
[TBL] [Abstract][Full Text] [Related]
32. Pharmacophore modeling of diverse classes of p38 MAP kinase inhibitors.
Sarma R; Sinha S; Ravikumar M; Kishore Kumar M; Mahmood SK
Eur J Med Chem; 2008 Dec; 43(12):2870-6. PubMed ID: 18406015
[TBL] [Abstract][Full Text] [Related]
33. Statistical tools for virtual screening.
Krumrine JR; Maynard AT; Lerman CL
J Med Chem; 2005 Nov; 48(23):7477-81. PubMed ID: 16279807
[TBL] [Abstract][Full Text] [Related]
34. Multiple N-methylation by a designed approach enhances receptor selectivity.
Chatterjee J; Ovadia O; Zahn G; Marinelli L; Hoffman A; Gilon C; Kessler H
J Med Chem; 2007 Nov; 50(24):5878-81. PubMed ID: 17973471
[TBL] [Abstract][Full Text] [Related]
35. Conformational sampling of bioactive molecules: a comparative study.
Agrafiotis DK; Gibbs AC; Zhu F; Izrailev S; Martin E
J Chem Inf Model; 2007; 47(3):1067-86. PubMed ID: 17411028
[TBL] [Abstract][Full Text] [Related]
36. Modeling of drug-transporter interactions using structural information.
Winiwarter S; Hilgendorf C
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):95-103. PubMed ID: 18175272
[TBL] [Abstract][Full Text] [Related]
37. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
Wei HY; Lu CS; Lin TH
J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
[TBL] [Abstract][Full Text] [Related]
38. Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode.
Angell RM; Bamborough P; Cleasby A; Cockerill SG; Jones KL; Mooney CJ; Somers DO; Walker AL
Bioorg Med Chem Lett; 2008 Jan; 18(1):318-23. PubMed ID: 18006306
[TBL] [Abstract][Full Text] [Related]
39. 3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds with dual function.
Ilas J; Jakopin Z; Borstnar T; Stegnar M; Kikelj D
J Med Chem; 2008 Sep; 51(18):5617-29. PubMed ID: 18729445
[TBL] [Abstract][Full Text] [Related]
40. Novel approach for chemotype hopping based on annotated databases of chemically feasible fragments and a prospective case study: new melanin concentrating hormone antagonists.
Oyarzabal J; Howe T; Alcazar J; Andrés JI; Alvarez RM; Dautzenberg F; Iturrino L; Martínez S; Van der Linden I
J Med Chem; 2009 Apr; 52(7):2076-89. PubMed ID: 19290642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
